Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2020-06-11 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2019年度股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2019 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It details the convening, attendance, voting procedures, and results of the AGM held on June 11, 2020. The document includes voting results on various proposals such as the 2019 financial report, profit distribution plan, board and supervisory reports, and other corporate matters. It is not the AGM presentation materials themselves but a legal opinion on the AGM process and outcomes. This type of document is best classified under Declaration of Voting Results & Voting Rights Announcements (DVA) because it officially reports the voting results of the shareholder meeting. The document length (7060 characters) and content confirm it is not a brief announcement or a full annual report but a detailed legal opinion on the AGM voting results.
2020-06-11 Chinese
2019年度股东大会会议决议暨中小投资者表决结果公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as an announcement of the 2019 Annual General Meeting (AGM) resolutions and voting results of 嘉事堂药业股份有限公司. It details the meeting date, attendance, voting results on various agenda items including financial reports, profit distribution plans, and board changes. The document includes voting percentages and legal opinions confirming the validity of the meeting and resolutions. It does not contain the full annual report or financial statements themselves but reports on the outcomes of the AGM and shareholder votes. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5734 characters, which is sufficient for detailed voting results but not a full annual report. Therefore, the correct classification is DVA with high confidence.
2020-06-11 Chinese
关于召开2019年度股东大会的通知（更新后）
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2019 Annual General Meeting (AGM) of 嘉事堂药业股份有限公司. It includes information about the meeting date, location, agenda items to be voted on (such as the 2019 annual work reports, financial reports, profit distribution plan, and other corporate governance matters), voting procedures, registration details, and proxy forms. The content is focused on informing shareholders about the AGM logistics and agenda rather than presenting the actual annual report or financial statements. The document is not a transcript, financial report, or announcement of voting results but rather the official notification and materials related to the AGM itself. Therefore, it fits the category of AGM Information (AGM-R). The document length (5880 characters) and detailed procedural content support this classification with high confidence.
2020-04-28 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company 嘉事堂药业股份有限公司 regarding a change in accounting policy due to the adoption of a new revenue recognition standard issued by the Ministry of Finance. It details the reasons for the change, the previous and new accounting policies, the impact on the company, and includes opinions from the board, independent directors, and the supervisory board. The document is relatively short (2136 characters) and does not contain actual financial statements or detailed financial data. It is an announcement about a change in accounting policy rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-04-28 Chinese
第六届董事会第八次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of resolutions passed at the sixth board of directors' eighth meeting of 嘉事堂药业股份有限公司, held on April 28, 2020. It includes approval of the 2020 first quarter report and a change in accounting policy. The document references the full 2020 first quarter report and other related announcements available on external websites, indicating that this document itself is not the full quarterly report but an announcement of board decisions and approvals. The document length is short (1189 characters), and it mainly reports meeting resolutions and voting results. Therefore, it fits best as a Regulatory Filing (RNS) rather than the full Interim/Quarterly Report (IR) or Annual Report (10-K).
2020-04-28 Chinese
2019年年度报告（更新后）
Annual Report Classification · 100% confidence The document is titled as the 2019 Annual Report of 嘉事堂药业股份有限公司 (Cachet Pharmaceutical Co., Ltd.). It contains detailed sections typical of an annual report, including company overview, financial data, business analysis, management discussion, and financial statements. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of comprehensive financial figures, business descriptions, and governance information confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K).
2020-04-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.